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The commensal microbiota impacts specific immune
cell populations and their functions at peripheral
sites, such as gut mucosal tissues. However, it re-
mains unknown whether gut microbiota control
immunity through regulation of hematopoiesis at
primary immune sites. We reveal that germ-free
mice display reduced proportions and differentiation
potential of specific myeloid cell progenitors of
both yolk sac and bone marrow origin. Homeostatic
innate immune defects may lead to impaired early
responses to pathogens. Indeed, following systemic
infection with Listeria monocytogenes, germ-free
and oral-antibiotic-treated mice display increased
pathogen burden and acute death. Recolonization
of germ-free mice with a complex microbiota re-
stores defects in myelopoiesis and resistance to
Listeria. These findings reveal that gut bacteria direct
innate immune cell development via promoting
hematopoiesis, contributing to our appreciation of
the deep evolutionary connection betweenmammals
and their microbiota.
INTRODUCTION
The vast majority of our interactions with bacteria are symbiotic
in nature, consisting of colonization by a complex and diverse
microbiota that inhabit humans for life. Rather than causing
inflammation, commensal microbes largely direct beneficial
immune functions and often engender health. In particular, the
microbiota shapes global immune cell repertoires, thereby
altering host susceptibility to inflammation and infection at sites
of colonization (Hill et al., 2012; Kamada et al., 2012; Mazmanian
et al., 2008; Naik et al., 2012). Specific gut bacteria or bacterial
products have been shown to suppress intestinal inflammation
(e.g., colitis) in mice through a variety of immune mechanisms
(Atarashi et al., 2013; Round and Mazmanian, 2010; Smith
et al., 2013). Furthermore, the impact of commensal microbes
on host immune responses is not limited to mucosal interfaces
but extends to systemic compartments; gut microbes regulate374 Cell Host & Microbe 15, 374–381, March 12, 2014 ª2014 Elsevieimmune responses that influence organ-specific autoimmunity
in animal models of multiple sclerosis, rheumatoid arthritis, and
type 1 diabetes (Lee et al., 2011; Markle et al., 2013; Wu et al.,
2010). While numerous examples illustrate how the microbiota
contributes to immune function at mucosal and systemic sites,
little is known about the influences of gut bacteria on cellular
development within primary immune tissues.
The immune system begins to develop in utero, but full matu-
ration requires both genetic and environmental signals that
further shape immunity after birth. Lymphoid and myeloid cells
develop largely from hematopoietic stem cells (HSCs) within pri-
mary tissues, where molecular cues orchestrate immune cell
differentiation from uncommitted HSCs and progenitor cells via
regulation of transcription factors and epigenetic modifications
(Weissman, 1994). Additionally, certain phagocyte populations
(including Langerhans cells and microglia), derived from embry-
onic precursors, are maintained independently of HSCs (Sie-
weke and Allen, 2013). Genetic contributions (i.e., molecular
cues encoded by the host genome) to lineage commitment
pathways that control the myeloid repertoire are well studied
(Georgopoulos, 2002). However, environmental factors that
influence hematopoiesis have not been extensively defined.
Based on emerging data showing that the microbiota represents
an integral environmental factor in shaping numerous features
of the immune system, we reasoned that gut bacteria may be
controlling central immunity. We report herein that commensal
microbes promote the maintenance of both HSC- and embryo-
derived myeloid cells during steady-state conditions. The
absence of commensal microbes leads to defects in several
innate immune cell populations (including neutrophils, mono-
cytes, and macrophages) within systemic sites. By controlling
the differentiation of innate immune cells, the gut microbiota pre-
pares the host to rapidly mount immune responses upon path-
ogen encounter, as germ-free and antibiotic-treated mice are
impaired in clearance of systemic bacterial infection. Our study
reveals that gut microbes evolved to actively shape immunity
at its core—via regulation of hematopoiesis.
RESULTS
Germ-free Animals Display Global Defects in Innate
Immune Cells
The commensal gut microbiota profoundly influences cellular
proportions, migration, and functions of various immune cellr Inc.
Figure 1. GF Mice Are Deficient in Resident Myeloid Cell Populations in the Spleen and Bone Marrow
(A–C) Splenic phagocyte profile among SPF and GF mice. Representative flow cytometry plots (A), cell proportions (B), and total cell number (C) of CD11blo
F4/80hi and CD11bhi F4/80lo splenic cells in SPF and GF mice. (D–F) Bone marrow populations of neutrophils (Gr1hi CD115neg) and monocytes (Gr1hi CD115hi)
among SPF and GFmice. Shown are representative flow cytometry plots (D), cell proportions (E), and total cell number (F) within the bone marrow of SPF and GF
mice. For all panels, data are representative of at least three independent trials with nR 4 mice/group. Each symbol represents data from a single animal. Error
bars represent standard error of mean (SEM). *p < 0.05, **p < 0.01. PMN, polymorphonuclear cells; Mono, monocytes. See also Figure S1.
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illustrating how gut bacteria modulate innate and adaptive
immune responses at mucosal surfaces during infection, inflam-
mation, and autoimmunity (Kamada et al., 2013; Round andMaz-
manian, 2009).With such pervasive effects, we reasoned that the
microbiota may regulate hematopoiesis—the developmental
programming of the immune system. Initially, to determine if the
microbiota has global effects on systemic immune cell popula-
tions,weprofiledmyeloid cells in the spleen of colonized (specific
pathogen-free, SPF) and germ-free (GF) mice. Indeed, GF ani-
mals display reduced proportions and total numbers of F4/80hi
and F4/80lo cells compared to SPF mice (Figures 1A–1C).
F4/80hi cells are mainly macrophages, while F4/80lo splenocytes
are a heterogeneous population of macrophages, monocytes,
and neutrophils (Schulz et al., 2012). Intriguingly, all three cell
subsets are reduced inGFmice (see Figure S1A available online).
Furthermore, treatment of SPF mice with antibiotics also results
in diminishedmyeloid cell populations in the spleen (Figure S1B).
Thus, gut bacteria dynamically influence innate immune cell
proportions at secondary immune sites in the periphery.
Myeloid cell precursors differentiate into various phagocyte
lineages that are stored in the bone marrow and are a major
source of cells that populate peripheral tissues (Geissmann
et al., 2010). The reduction of splenic macrophages, monocytes,
and neutrophils in GF mice suggests that defects in host
immunity may include compromised development in primary
immune sites. Accordingly, we observed a reduction of myeloid
cells within the bone marrow of GF mice (Figures 1D–1F). ACell Hosimilar decrease was observed in the liver, a site of alternative
immune cell development (Figure S1C). A global defect in
myeloid cell populations in primary immune sites of GF mice
demonstrates that gut bacteria shape the architecture of the
immune system early in cellular development.
Commensal Microbes Enhance Myelopoiesis
We reasoned that reductions in several phagocytic cell subsets
in GF mice may reflect a primary defect in the maintenance of
myeloid cell populations. To test if commensal microbes pro-
mote myelopoiesis, we pulsed SPF and GF mice with 5-ethy-
nyl-20-deoxyuridine (EdU), a thymidine analog, to compare the
percentage of dividing leukocytes. Both F4/80hi and F4/80lo
phagocytes from GF mice show reduced EdU incorporation
compared to SPF animals (Figures 2A and 2B). F4/80hi macro-
phages are largely derived from embryonic yolk sac progenitors
and are maintained independently of HSCs (Schulz et al., 2012;
Sieweke and Allen, 2013). F4/80lo leukocytes, however, are of
hematopoietic origin, and reduced EdU incorporation by these
cells in GF mice indicates defects in the expansion and/or
differentiation of bone marrow progenitor cells (Schulz et al.,
2012). These studies uncover a role for commensal microbes
in promoting the maintenance of both splenic yolk sac-derived
and HSC-derived myeloid cells.
The reduction of F4/80lo cells in GF mice led us to further
investigate the contribution of commensal microbes on HSCs
and myeloid progenitor cells in the bone marrow. No differences
were detected in the proportion or differentiation potential ofst & Microbe 15, 374–381, March 12, 2014 ª2014 Elsevier Inc. 375
Figure 2. The Microbiota Directs Myelopoiesis
The percentage of F4/80hi CD11b+ (A) and F4/80lo CD11b+
(B) splenocytes with incorporated EdU, following single
dose administration. (C) The frequency of LKSCD34+
FcgRhi granulocyte and/or monocyte progenitors (GMPs)
among lineage negative (Lin) progenitors from bone
marrow of SPF and GF mice, as assessed by flow cy-
tometry. (D) Distribution of cell types following purified
LKSCD34+FcgRhi cell culture in methylcellulose me-
dium. Colonies were identified and counted to assess the
proportion of granulocyte-monocytes (GM-CFU; black),
granulocytes (G-CFU; blue) and monocytes (M-CFU;
green). (E) Total numbers of c-Kit+ CD11b progenitors
from methylcellulose cultures of LKSCD34+FcgRhi pro-
genitors, as assessed by flow cytometry. (F) Cells
harvested from methylcellulose cultures of LKSCD34+
FcgRhi progenitors were replated at equal numbers in
fresh methylcellulose, and cultured to assess their colony-
forming capacity. (G and H) Splenic cells isolated from
SPF and GF mice were cultured in methylcellulose to
assess the colony-forming capacity of progenitors from
SPF andGFmice. Total CFUs (G) andGM-CFUs, G-CFUs,
and M-CFUs (H) are shown. For each panel, data are
representative of at least two to three independent trials
with n R 4/group. Each symbol represents data from a
single animal. Error bars represent SEM. *p < 0.05 for all
panels. **p < 0.05 (comparing total CFU between SPF and
GF for D and H), ***p < 0.05 (comparing G-CFU between
SPF and GF for D and H), and ****p < 0.05 (comparing
M-CFU between SPF and GF for D and H). CFU, colony-
forming units. See also Figure S2.
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cells (total lineage-restricted progenitors), or common myeloid
progenitor cells (CMPs) between SPF and GF mice (Figures
S2A–S2F). Remarkably, GF mice are significantly reduced in
the proportion of bone marrow granulocyte and/or monocyte
progenitors (GMPs), identified as LKSCD34+ FcgRhi cells (Fig-
ure 2C). GMPs consist of progenitor cells, downstream of
HSCs and CMPs during hematopoiesis, with restricted myeloid
differentiation potential (Akashi et al., 2000). To further examine
the effects of gut microbiota on innate immune cells, we tested
if commensal microbes affect the differentiation potential and
self-maintenance capacity of GMPs. Methylcellulose culture of
LKSCD34+FcgRhi cells from GF mice displayed reduced
granulocyte (G-CFU) and monocyte (M-CFU) colony formation
compared to cells from SPF mice (Figure 2D). Furthermore,
LKSCD34+FcgRhi cells isolated from GF mice in primary meth-
ylcellulose culture yielded fewer c-Kit+ CD11b progenitor cells
compared to SPF GMPs (Figure 2E). This suggests the ability
of GMPs to maintain cells with progenitor potential is defective
in the absence of commensal microbes (Rodrigues et al.,
2008). Consistent with this notion, secondary cultures of unfrac-
tionated cells derived from GF GMPs generate fewer colonies
compared to cells isolated from SPF mice (Figure 2F). The
commensal microbiota therefore promotes steady-state myelo-
poiesis by specifically maintaining GMP proportions and
enhancing their differentiation into mature myeloid cells in the
bone marrow.
Extramedullary hematopoiesis (outside the bone marrow)
further contributes to the maintenance and inflammatory re-
sponses of tissue-resident phagocytic cells (Jenkins et al.,376 Cell Host & Microbe 15, 374–381, March 12, 2014 ª2014 Elsevie2011; Massberg et al., 2007; Robbins et al., 2012; Swirski
et al., 2009). We therefore investigated whether commensal mi-
crobes influence the hematopoietic potential of progenitors
located in the spleen. Similar to GMPs from the bone marrow,
splenocytes isolated from GF mice displayed reduced colony
formation in methylcellulose, compared to SPFmice, with signif-
icant reductions in both neutrophil and monocyte production
(Figures 2G and 2H). Overall, we conclude that the microbiota
shapes innate immune profiles by promoting myeloid progenitor
development and differentiation in the bone marrow and extra-
medullary sites.
Tissue-Resident Phagocytes Mediate Protection by
Commensal Microbes
Innate immune cells are the first responders to infection, medi-
ating early pathogen control and coordinating downstream
immune reactions (Kastenmu¨ller et al., 2012; Shi and Pamer,
2011). We sought to test the impact of commensal microbes
on myeloid cell differentiation by employing infection models
where innate immunity is vital for an effective immune response.
SPF and GF mice were infected intravenously (i.v.) with the
model pathogen Listeria monocytogenes. SPF mice challenged
systemically with L. monocytogenes effectively control infection,
as previously described (Figure 3A) (Serbina et al., 2012; Shi
et al., 2011). However, GF mice rapidly succumb at the same
inoculum (Figure 3A). Heightened susceptibility to infection
among GF mice was associated with a significant increase in
splenic and liver bacterial burden 24 and 72 hr postinfection
(hpi), demonstrating a defect in early resistance to Listeria
infection (Figures 3B, 3C, and S3A). Susceptibility to infectionr Inc.
Figure 3. The Microbiota Promote Early Resistance to Systemic Infection by L. monocytogenes via Tissue-Resident Cells
(A–C) SPF and GF mice were infected with L. monocytogenes and assessed for survival (A) and splenic bacterial burden at 24 (B) and 72 (C) hours postinfection
(hpi). SPF mice treated with antibiotics (Abx) and untreated controls (Ctl) were infected with L. monocytogenes, and splenic bacterial burden was measured
72 hpi (D). SPF and GF mice were depleted of tissue-resident cells prior to infection with L. monocytogenes and assessed for splenic bacterial burden 24 hpi (E)
and survival (F). Splenic bacterial burden, 24 hpi, following transfer of splenic CD11b+ cells from SPF or GF donors (G). For all panels, data are representative of at
least two to three independent trials with nR 4/group. Each symbol represents data from a single animal. Error bars represent SEM. *p < 0.05, **p < 0.01, ***p <
0.05 log rank test used for survival curves in (A). CL, clodronate-loaded liposomes. See also Figure S3.
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increased disease burden following systemic challenge with
Staphylococcus aureus (Figure S3B). Interestingly, SPF mice
treated orally with broad-spectrum antibiotics are also impaired
in controlling Listeria, indicating protection by commensal mi-
crobes is an active process and is subject to loss following
depletion of gut microbiota (Figure 3D). Collectively, these data
reveal that commensal microbes are critical for rapid and potent
systemic immune responses to acute bacterial infection.
To confirm that defects in myelopoiesis contribute to
increased disease burden in GF mice, phagocytic cells were
depleted with clodronate-loaded liposomes (CL) prior to
infection with L. monocytogenes (van Rooijen et al., 1996). CL
pretreatment increased susceptibility to Listeria infection (Fig-
ure 3E), confirming the importance of resident cells in pathogen
resistance (Aichele et al., 2003; Kastenmu¨ller et al., 2012). Impor-
tantly, depletion of resident phagocytes rendered both SPF andCell HoGF mice equally susceptible to infection, resulting in similar
splenic disease burden 24 hpi (Figure 3E) and rapid death within
48 hpi (Figure 3F). While functional defects in myeloid cells may
potentially contribute to increased disease in GF mice, we did
not detect differences during in vitro Listeria killing by macro-
phages from SPF or GF mice (Figure S3C). Furthermore,
CD11b+ myeloid cells isolated from either SPF or GF donors
were equally sufficient in providing protection when transferred
into GF mice prior to infection (Figure 3G), suggesting reduced
cell proportions are likely the primary defect in GF mice. These
studies confirm the importance of microbiota-driven myelopoie-
sis in promoting host resistance during systemic infection.
Effective responses to L. monocytogenes require coordination
between innate and adaptive immune cells, resulting in pathogen
clearanceandprotective immunity (Pamer, 2004). Thus,we inves-
tigated whether additional immune cells beyond tissue-resident
phagocytes may mediate commensal-derived protection tost & Microbe 15, 374–381, March 12, 2014 ª2014 Elsevier Inc. 377
Figure 4. Recolonization of GF Mice Restores Immune Integrity against Systemic Listeriosis
(A) Neutrophil (GR1hi CD115) and (B) monocyte (GR1hi CD115+) bone marrow profiles from SPF, GF, recolonized GF mice, and MAMP- or SCFA-treated GF
mice. (C) F4/80hi splenic macrophage profile among SPF, GF, recolonized GF mice, and GF mice treated with MAMPs or SCFAs. (D) Splenic bacterial
burden 72 hpi among SPF, GF, and recolonized GF mice infected with L. monocytogenes. For all panels, data are representative of at least two independent
trials with n R 4/group. Each symbol represents data from a single animal. Error bars represent standard error of mean (SEM). *p < 0.05, **p < 0.01. Recol,
recolonized; MAMPs, molecular-associated molecular patterns; SCFAs, short-chain fatty acids. See also Figure S4.
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for protection by the microbiota during acute infection (Fig-
ure S3D), nor are GF mice deficient in developing long-term pro-
tective immunity against subsequent infection (Figure S3E).
Furthermore, the selective expansion of myeloid cells during
acute infection, calledemergencyhematopoiesis,which isneces-
sary for mediating delayed resistance to L. monocytogenes
(following 48 hpi), was maintained in GF mice (Figure S3F) (Ser-
bina et al., 2003, 2009). Finally,while there are fewer inflammatory
neutrophils and monocytes recruited to the spleen of GF mice
following infection (Figure S3G), a possible consequence of
increased apoptosis (Figure S3H), these cells were not required
for commensal-mediated protection against L. monocytogenes
(Figures S3I and S3J). Together, these findings demonstrate
that hematopoietic defects in tissue-resident myeloid cells prior
to infection of GF mice (i.e., during steady-state hematopoiesis)
is the primary cause of impaired control of Listeria.
Commensal Bacterial Signals Mediate Maintenance
of Myelopoiesis
The molecular mechanism(s) by which commensal microbes
promote steady-state expansion of bone marrow- and yolk
sac-derived myeloid cells remains unknown. Microbial-associ-
ated molecular patterns (MAMPs) and microbial metabolites,
such as short-chain fatty acids (SCFAs), have been shown
to modulate various aspects of the host immune response
(Chu and Mazmanian, 2013; Clarke et al., 2010; Smith et al.,
2013). Furthermore, MyD88 (an adaptor for recognition of
many MAMPs) was recently shown to promote GMP expansion
and differentiation (Fiedler et al., 2013). Accordingly, we sought
to address whether commensal-derived factors are involved
in the maintenance of myeloid cells under naive conditions.
Recolonization of GF mice with a complex microbiota and oral
treatment with MAMPs, but not SCFAs, was sufficient to pro-
mote recovery of GMP-derived myeloid cells (neutrophils and
monocytes) within the bone marrow (Figures 4A and 4B). Impor-
tantly, only recolonization of GF mice with an SPF microbiota
was sufficient to restore splenic populations of F4/80hi macro-378 Cell Host & Microbe 15, 374–381, March 12, 2014 ª2014 Elseviephages and F4/80lo splenocytes (i.e., neutrophils, monocytes,
and macrophages) (Figures 4C and S4A–S4D). Therefore, while
MAMP treatment is necessary for the maintenance of bone
marrow-derived myeloid cells, colonization with a live and com-
plex microbiota is required to promote complete myelopoiesis
(including yolk sac-derived macrophages). Finally, only recoloni-
zation of GF animals, and not oral MAMP treatment, was suffi-
cient to restore the defect in GF mice to systemic challenge
with L. monocytogenes (Figure 4D; data not shown). Collectively,
these studies reveal that the microbiota provide complex
molecular signals that actively promote the hematopoietic differ-
entiation of myeloid cells, resulting in peripheral phagocyte
populations that function as sentinels for the early detection
and control of systemic bacterial infection.
DISCUSSION
Advances in understanding host-microbial symbiosis have
revealed that, remarkably, the gut microbiota controls the
phenotype, migration, and activity of multiple innate and adap-
tive cells (Belkaid and Naik, 2013; Chu and Mazmanian, 2013).
Disruption or alteration of commensal communities impacts
host susceptibility to various disorders, particularly at sites of
microbial colonization such as the intestines, respiratory mu-
cosa, and skin epithelium (Kamada et al., 2013). In addition to
modulating functional immune outcomes, the microbiota is
necessary for maintaining systemic populations of neutrophils
in the circulation and CD4+ T cells in the spleen (Bugl et al.,
2013; Mazmanian et al., 2005), suggesting a possible contribu-
tion by gutmicrobiota to the development of the immune system.
Herein, we reveal that gut bacteria regulate hematopoiesis
within primary immune sites, providing a unifying explanation
for previous observations of the widespread effects by the
microbiota on the immune system. Specifically, our study un-
covers that the microbiota promotes steady-state myeloid cell
development by driving the expansion of yolk sac-derived mac-
rophages, as well as enhancing the numbers and differentiation
potential of GMPs in the bone marrow. We propose a modelr Inc.
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treated mice compromises multiple tissue-resident innate im-
mune cell populations prior to infection, leading to blunted early
responses upon subsequent pathogen encounter (see diagram
in Figure S4E). While our studies focus on innate immunity
due to its role in rapid control of early Listeria infection, impaired
microbiota-mediated hematopoiesis may also extend to the
adaptive immune system, providing an explanation for observa-
tions that peripheral T, B, and iNKT cell populations are altered
in GF mice (Ivanov et al., 2008; Macpherson and Uhr, 2004;
Mazmanian et al., 2005; Olszak et al., 2012).
How commensal microbes (presumably in the gut) are able to
control immune responses in distant sites such as the bone
marrow remains incompletely understood. It has recently been
shown that mice deficient in MyD88 signaling display reductions
in systemic myeloid cell populations and GMP numbers
(Fiedler et al., 2013; Ya´n˜ez et al., 2013), similar to our findings
in GF mice. Further, as microbial ligands have been detected
in systemic sites, including the bone marrow (Clarke et al.,
2010), commensal-derived MAMPs that originate in the gut
may mediate steady-state myelopoiesis in primary immune
sites. Accordingly, we show that oral treatment with MAMPs is
sufficient to rescue GMP-mediated expansion of neutrophils
and monocytes. However, MAMP treatment alone is inadequate
to expand splenic F4/80hi and F4/80lo cells, indicating additional
commensal-derived signals are necessary to influence site-
specific HSC and yolk sac-derived myeloid cells. Interestingly,
recolonization of adult GF mice with SPF microbiota is insuffi-
cient to restore splenic F4/80hi macrophages to the levels
found in SPF mice. This may suggest that complete rescue re-
quires either colonization from birth or colonization with specific
microbes that were not transferred into GF mice. In addition to
MAMPs translocating from the gut into the circulation, other ex-
planations for how the microbiota affects hematopoiesis may
include a role for myeloid cell growth factors. In support of this
notion, preliminary data suggest that GF mice are reduced in
M-CSF transcript levels in the gut (data not shown), though
further work is need to uncover the complex molecular mecha-
nism(s) by which commensal bacteria signal from the gut to
distant primary immune organs.
Finally, we speculate that these findings may be relevant to
human infections. The spread of antibiotic resistance among
pathogens, paired with a dwindling supply of effective anti-
biotics, has necessitated alternative strategies to combat infec-
tions (Khosravi and Mazmanian, 2013). Evidence that depletion
of the microbiota leads to transient immune suppression sug-
gests factors that disrupt commensal microbes, including
clinical antibiotic use may, paradoxically, be a risk factor for sus-
ceptibility to opportunistic pathogens. The concepts proposed
herein, if validated in humans, may herald future medical
approaches that combine antibiotics with immunomodulatory
microbial molecules as revolutionary combination treatments
to address the re-emerging crisis of infectious diseases.EXPERIMENTAL PROCEDURES
Animal Studies
SPF C57BL/6 mice were purchased from Taconic Farms. Germ-free (GF)
C57BL/6 and C57BL/6Rag/mice were bred and raised in sterile gnotobioticCell Hoflexible film isolators at the California Institute of Technology. Mice at 8–
12 weeks of age were infected via retro-orbital injection with 3 3 104 col-
ony-forming units (CFUs) of Listeria monocytogenes 10403S. Splenic and liver
bacterial CFU were assessed 24–72 hpi by microbiological plating. For micro-
biota depletion studies, SPF mice were treated with 1 mg/ml of ampicillin
(Auromedics), neomycin sulfate (Fisher), streptomycin (Sigma), and 0.5 mg/
ml of vancomycin (Sagent) in the drinking water for 4–5 weeks. Mice were
taken off antibiotics 4 days prior to infection. Antibiotic-treated and untreated
SPF mice were infected with 3 3 104 CFU of L. monocytogenes, and splenic
bacterial burden was assessed 72 hpi. GF mice were recolonized by gavage
with cecal contents of SPF mice. Alternatively, GF mice were treated with
MAMPs through the addition of heat-killed Escherichia coli strain Nissle
(Lodinova´-Za´dnikova´ and Sonnenborn, 1997) or autoclaved cecal contents
from SPF mice in water (1 3 109 CFU/ml in drinking water). For treatment
with short-chain fatty acids, sodium proprionate (Sigma), sodium butyrate
(Sigma), and sodium acetate (Sigma) were added to drinking water at previ-
ously described concentrations (25 mM, 40 mM, and 67.5 mM, respectively)
(Smith et al., 2013). Mice were recolonized or treated with microbial ligands
or metabolites for 4 weeks prior to cellular analysis and infectious studies.
Animals were cared for under established protocols and IACUC guidelines
from the California Institute of Technology.
Cellular Analysis
Spleens were eithermechanically disrupted via passage through 100 mmmesh
filters (BD Biosciences) or digested in 0.5 mg/ml of Collagenase D (Roche) and
0.5 mg/ml of DNase I (Worthington). Bone marrow was collected by flushing
femurs with PBS containing 0.5% BSA and 5 mM EDTA. Single-cell suspen-
sions were removed of red blood cells (RBC lysis buffer, Sigma). Mature
myeloid cells were evaluated by staining with antibodies to GR1 (RB6-8C5),
Ly6C (HK 1.4), CD11b (M1/70), CD115 (AFS98), and F4/80 (BM8). Mouse
hematopoietic stem and progenitor cells (HSPCs) were isolated from bone
marrow by a combination of MACS magnetic bead purification (Miltenyi) and
fluorescence-activated cell sorting (FACS). Lineage marker-negative cells
(Lin) were first separated using a MACS lineage cell depletion kit (containing
antibodies against CD5 [53-7.3], CD45R [B220; RA3-6B2], CD11b, Gr-1, 7-4
[15BS], and Ter-119 [Ter-119]) and an autoMACS Separator (Miltentyi). Lin
cells were then further stained with c-Kit (CD117; 3C1), Sca-1 (D7), CD16/
CD32 (93), CD34 (RAM34). Populations of LKS+ cells (Lin c-Kit+ Sca-1+;
HSCs and MPPs), Lin c-Kit+ Sca-1 (LKS), CD34+ FcgRlo cells (CMPs),
and LKS CD34+ FcgRhi cells (GMPs) were analyzed by flow cytometry.
LKS CD34+ FcgRhi cells were FACS sorted using an Aria cell sorter (BD Bio-
sciences). Steady-state cell proliferation wasmeasured by intraperitoneal (i.p.)
injection of 500 mg EdU (Life Technologies), and EdU incorporation among
splenic myeloid cells was measured 24 hr later via Click-it EdU assay kit
(Life Technologies). Antibodies were purchased from eBioscience, BD Biosci-
ence, Miltenyi, or Biolegend. Data were collected on a FACSCalibur or LSR
Fortessa (BD Bioscience) and analyzed with FlowJo software (TreeStar).
Cell Depletion and Adoptive Transfer
Resident phagocytes were depleted by intravenous (i.v.) treatment with 100 ml
of clodronate-loaded liposomes (CL; FormuMax) 48 hr prior to infection.
CD11b+ splenocytes were isolated from naive SPF and GF mice using
CD11b microbeads (Miltenyi). 2 3 106 CD11b+ cells (>90% purity) were
transferred into GF recipients 24 hr prior to infection with L. monocytogenes.
CFU burden was assessed 24 hpi.
CFU Assays
To evaluate hematopoietic potential, 1 3 103 Lin or 1 3 103 LKS CD34+
FcgRhi cells or 2 3 105 splenocytes were plated in triplicate in MethoCult
GF M3434 (StemCell Technologies) methylcellulose-based medium and incu-
bated for 7 days in 37C with 5% CO2, after which the colonies were counted
on the basis of their morphological characteristics in accordance with the
manufacturer’s instructions. On the same day, cells were harvested, counted,
and stained for c-Kit and CD11b expression for progenitor quantification by
flow cytometry. For replating assays, 5 3 104 cells from the first culture
were plated in triplicate in a secondary culture of fresh MethoCult GF
M3434, and colonies were counted after 7 days of incubation.st & Microbe 15, 374–381, March 12, 2014 ª2014 Elsevier Inc. 379
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